What the study found
The article says the trial did not show a clear neonatal benefit from targeting a higher maternal blood pressure during caesarean birth. It notes that the primary outcome, mean umbilical artery pH, was identical between groups, while the claim about fetal acidaemia came from a secondary outcome with too few events to be conclusive.
Why the authors say this matters
The authors say maintaining maternal blood pressure during caesarean birth is good practice, and they conclude that reducing maternal hypotension and nausea is clinically relevant. They also say the findings about fetal acidaemia should be interpreted with caution because the study does not support a meaningful neonatal advantage.
What the researchers tested
Chen et al. compared maternal systolic blood pressure targets during caesarean birth in a large multicentre trial. The article describes a target of 90% of baseline blood pressure and compares this with the control approach used in the trial, which involved reactive bolus dosing rather than prophylactic vasopressor infusions.
What worked and what didn't
Targeting 90% of baseline blood pressure reduced maternal hypotension, severe hypotension, nausea, and vomiting. However, mean umbilical artery pH was identical between groups, base excess was identical, and Apgar scores were comparable. The article says the secondary fetal acidaemia finding rested on only 16 events across 1183 patients.
What to keep in mind
The article notes that the trial was powered for the primary outcome, not the secondary neonatal outcome. It also says the reactive bolus strategy may be less able to prevent hypotension than a prophylactic infusion, so it is unclear whether the observed differences were due to blood pressure targets themselves or to the dosing approach.
Key points
- The article says the trial did not show a clear neonatal benefit from a higher maternal blood pressure target.
- Mean umbilical artery pH was identical between groups, which was the trial’s primary outcome.
- Targeting 90% of baseline blood pressure reduced maternal hypotension, severe hypotension, nausea, and vomiting.
- The fetal acidaemia claim came from a secondary outcome with only 16 events across 1183 patients.
- The article says the reactive bolus strategy may have limited prevention of hypotension compared with prophylactic infusion.
Disclosure
- Research title:
- Higher blood pressure target reduced maternal hypotension, not proven neonatal benefit
- Authors:
- Mathew Lyons
- Institutions:
- University of Edinburgh
- Publication date:
- 2026-04-28
- OpenAlex record:
- View
Get the weekly research newsletter
Stay current with peer-reviewed research without reading academic papers — one filtered digest, every Friday.